Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun 27;21(7):841.
doi: 10.3390/molecules21070841.

Synthesis and Evaluation of Ciprofloxacin-Nitroxide Conjugates as Anti-Biofilm Agents

Affiliations

Synthesis and Evaluation of Ciprofloxacin-Nitroxide Conjugates as Anti-Biofilm Agents

Anthony D Verderosa et al. Molecules. .

Abstract

As bacterial biofilms are often refractory to conventional antimicrobials, the need for alternative and/or novel strategies for the treatment of biofilm related infections has become of paramount importance. Herein, we report the synthesis of novel hybrid molecules comprised of two different hindered nitroxides linked to the piperazinyl secondary amine of ciprofloxacin via a tertiary amine linker achieved utilising reductive amination. The corresponding methoxyamine derivatives were prepared alongside their radical-containing counterparts as controls. Subsequent biological evaluation of the hybrid compounds on preformed P. aeruginosa flow cell biofilms divulged significant dispersal and eradication abilities for ciprofloxacin-nitroxide hybrid compound 10 (up to 95% eradication of mature biofilms at 40 μM). Importantly, these hybrids represent the first dual-action antimicrobial-nitroxide agents, which harness the dispersal properties of the nitroxide moiety to circumvent the well-known resistance of biofilms to treatment with antimicrobial agents.

Keywords: antibiotic; biofilm; ciprofloxacin; nitroxide; radical.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest

Figures

Figure 1
Figure 1
NO donor prodrug cephalosporin-3′-diazeniumdiolate 1.
Figure 2
Figure 2
Structure of nitric oxide and the general structure of a nitroxide.
Figure 3
Figure 3
Ciprofloxacin 2.
Figure 4
Figure 4
TEMPOL 3 and alcohol derivative 4.
Scheme 1
Scheme 1
Synthetic route to ciprofloxacin-nitroxide hybrid 10 and its corresponding methoxyamine derivative 11. Reagent and conditions: (a) (i) AcOH, MeOH 60 °C, 2 h. (ii) NaBH3CN, 50 °C, 24 h; (b) 2 M NaOH, MeOH, 50 °C, 5 h.
Scheme 2
Scheme 2
Synthetic route to ciprofloxacin-nitroxide hybrid 16 and its corresponding methoxyamine derivative 17. Reagent and conditions: (a) (i) AcOH, MeOH 60 °C, 2 h. (ii) NaBH3CN, 50 °C, 24 h; (b) 2 M NaOH, MeOH, 50 °C, 5 h.
Figure 5
Figure 5
Confocal laser scanning microscopy images of 2 day old pre-formed P. aeruginosa PA14 biofilms grown in a flow cell at 37 °C, treated with 20 µM of (b) 10; (c) 11; (d) 16; (e) 17 for 24 h and then visualized with SYTO-9 (stains live cells green) and propidium iodide (stains dead cells red, merged colors appear as yellow to red). Panel (a) shows an untreated P. aeruginosa PA14 biofilms after 3 days. The scale bars represent 40 µm in length for images (ac,e), and 50 μm for image (d). Each panel also shows the xy, yz and xz dimensions.
Figure 6
Figure 6
Confocal laser scanning microscopy images of 2 day old pre-formed P. aeruginosa PA14 biofilms grown in a flow cell at 37 °C, treated with 40 µM of (b) 10; (c) 11; (d) 16; (e) 17 for 24 h and then visualized with SYTO-9 (stains live cells green) and propidium iodide (stains dead cells red, merged colors appear as yellow to red). Panel (a) shows an untreated P. aeruginosa PA14 biofilms after 3 days. The scale bars represent 50 µm in length for images (ad). Each panel also shows the xy, yz and xz dimensions.
Figure 7
Figure 7
Flow cell effluent harvested from preformed P. aeruginosa PA14 biofilms treated with 40 µM of compounds 10, 11, 16, and 17 after 24 h. Bacteria were plated for enumeration.

Similar articles

Cited by

References

    1. Costerton J.W., Stewart P.S., Greenberg E.P. Bacterial biofilms: A common cause of persistent infections. Science. 1999;284:1318–1322. doi: 10.1126/science.284.5418.1318. - DOI - PubMed
    1. Hall-Stoodley L., Costerton J.W., Stoodley P. Bacterial biofilms: From the natural environment to infectious diseases. Nat. Rev. Microbiol. 2004;2:95–108. doi: 10.1038/nrmicro821. - DOI - PubMed
    1. Lynch A.S., Robertson G.T. Bacterial and fungal biofilm infections. Annu. Rev. Med. 2008;59:415–428. doi: 10.1146/annurev.med.59.110106.132000. - DOI - PubMed
    1. Vickery K., Hu H., Jacombs A.S., Bradshaw D.A., Deva A.K. A review of bacterial biofilms and their role in device-associated infection. Healthcare Infection. 2013;18:61–66. doi: 10.1071/HI12059. - DOI
    1. Percival S.L., Hill K.E., Williams D.W., Hooper S.J., Thomas D.W., Costerton J.W. A review of the scientific evidence for biofilms in wounds. Wound Repair Regen. 2012;20:647–657. doi: 10.1111/j.1524-475X.2012.00836.x. - DOI - PubMed

MeSH terms